• Technical Name
  • Immunoassay for A Newly Verified Oral Cancer Biomarker
  • Operator
  • Chang Gung University
  • Booth
  • Online display only
  • Contact
  • 吳淑芳
  • Email
  • kellyfangwu@gmail.com
Technical Description Immunoassays for quantifying a newly verified oral cancer biomarker “OCBM-1” in saliva specimens. Including two platforms: ELISA Kitcolloidal-gold based strip assay, which provides quantitativesemi-quantitative amounts of OCBM-1, respectively. Now the two products are at pilot production stage, which will be soon applied for pre-clinical verificationclinical validation.
Scientific Breakthrough 1. No routine biomarker test for oral cancer applied in clinical setting currently. Therefore, application of OCBM-1 will be beneficial for early detection of oral cancer.2. OCBM-1 is a newly verified salivary biomarker,no OCBM-1-related IVDinternational standard in the world. All the materials in the immunoassay are developedproduced by ourselves in Taiwan.
Industrial Applicability ELISA Kitcolloidal-gold based strip assay are common immunoassay platforms for protein measurement in clinical test. In this case, materials including antibodies, standard proteins,reagents were generated SOPs for large-scale productionquality control were established. The pipeline could be applied for developing immunoassays for other candidate protein biomarkers.
本網站使用您的Cookie於優化網站。繼續瀏覽網站即表示您同意本公司隱私權政策,您可至隱私權政策了解詳細資訊。